Properties (55)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
acquired_by_Takeda_Pharmaceutical_Company
|
| gptkbp:advertising |
develops a business strategy for growth
implements a market strategy for product launch |
| gptkbp:businessModel |
engages in business development activities
operates on a biotech business model |
| gptkbp:clinicalTrials |
conducts clinical research studies
involved in clinical development phases conducted clinical trials for drug candidates focus on rare neurological diseases |
| gptkbp:collaborations |
collaborates with academic institutions
engages in research collaborations with universities established clinical partnerships with hospitals |
| gptkbp:community_engagement |
engages with patient advocacy groups
|
| gptkbp:competitors |
conducts market research for drug candidates
|
| gptkbp:drugInterdiction |
develops novel drug candidates
focuses on drug efficacy in clinical trials utilizes a drug discovery platform |
| gptkbp:ecosystem |
part_of_the_biotech_ecosystem_in_Massachusetts
|
| gptkbp:employees |
approximately 50
|
| gptkbp:enrollment |
targets specific patient populations
|
| gptkbp:feedback |
aims to improve clinical outcomes for patients
|
| gptkbp:focus |
neuroscience
|
| gptkbp:founded |
2013
|
| gptkbp:founder |
gptkb:David_E._Schlessinger
|
| gptkbp:funding |
secured significant research funding
|
| gptkbp:future_plans |
aims to expand its drug portfolio
|
| gptkbp:goal |
develop treatments for neurological disorders
|
| gptkbp:headquarters |
gptkb:Cambridge,_Massachusetts
|
| gptkbp:healthcare |
prioritizes patient safety in trials
|
| https://www.w3.org/2000/01/rdf-schema#label |
Envoy Therapeutics
|
| gptkbp:innovation |
known for innovative approaches in drug development
|
| gptkbp:investmentFocus |
maintains investor relations for funding
raised funding from venture capital firms |
| gptkbp:leadership |
led by experienced biotech executives
|
| gptkbp:market |
focuses_on_the_US_market
|
| gptkbp:partnerships |
collaborated with various pharmaceutical companies
develops a partnership strategy with other firms |
| gptkbp:patentCitation |
holds multiple patents in drug development
|
| gptkbp:publications |
published research in scientific journals
|
| gptkbp:regulatoryCompliance |
ensures regulatory compliance for drug development
aims_for_FDA_approval_for_its_drug_candidates |
| gptkbp:research |
conducts scientific research in neuroscience
|
| gptkbp:research_areas |
evaluates therapeutic candidates for efficacy
explores various therapeutic areas of interest. focuses on CNS disorders pursues therapeutic innovation in neuroscience drug_discovery |
| gptkbp:supportRole |
has a scientific advisory board of experts
|
| gptkbp:targetMarket |
plans for market entry of new drugs
|
| gptkbp:technology |
proprietary platform
|
| gptkbp:tributaryOf |
has a pipeline of drug candidates
|
| gptkbp:type |
private company
|
| gptkbp:website |
www.envoytherapeutics.com
|
| gptkbp:youth_development |
involved in therapeutic development for mental health
|